COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 231: Articles 2301-2310  | Next

COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study
Vivaldi, G., Talaei, M., Pfeffer, P. E., Shaheen, S. O., Martineau, A. R.
10.1101/2024.06.28.24309666 — Posted: 2024-06-30
The COVID-19 pandemic in Canadas provinces: mitigation measures and outcomes
Grootendorst, P.
10.1101/2024.06.28.24309653 — Posted: 2024-06-30
Gut microbial profiling of COVID-19 patients in Uganda
Kateete, D. P., Lubega, C., Galiwango, R., Nasinghe, E., Mbabazi, M., Jjingo, D., Elliott, A.
10.1101/2024.06.28.601197 — Posted: 2024-06-30
AntiCPs-CompML: A Comprehensive Fast Track ML method to predict Anti-Corona Peptides
Bist, P. S., Bhattarai, S., Tayara, H., Chong, K. T.
10.1101/2024.06.27.601090 — Posted: 2024-06-29
Covid-19 vaccination decisions and impacts of vaccine mandates: A cross sectional survey of healthcare workers in Ontario, Canada
Chaufan, C., Hemsing, N., Moncrieffe, R.
10.1101/2024.06.23.24309372 — Posted: 2024-06-28
Admission systolic blood pressure and obesity correlate with fatal and severe acute COVID-19 in the population of New Orleans, LA.
Drouin, A., Liu, S., Theberge, M., Pulapaka, A. V., Zha, Y., Rittmeyer, W., Maylin, M., Rothwell, W. B., Adhikari, P., Raynaud, P., Ferdinand, K., Fusco, D.
10.1101/2024.06.27.24309604 — Posted: 2024-06-28
Epidemiological and phylogenetic analyses of public SARS-CoV-2 data from Malawi
Afuleni, M. K., Cahuantzi, R., Lythgoe, K. A., Mulaga, A. N., Hall, I., Johnson, O., House, T.
10.1101/2024.06.28.24309607 — Posted: 2024-06-28
Does COVID-19 Increase the Risk of Subsequent Kidney Diseases More Than Influenza? A Retrospective Cohort Study Using Real-World Data In the United States
Zhang, Y., Ghahramani, N., Chinchilli, V. M., Ba, D. M.
10.1101/2024.06.27.24309556 — Posted: 2024-06-28
Mortality risk in survivors of acute COVID-19 and the urinary proteome: Follow-up results from a multinational study that prospectively evaluated a proteomic urine test for early and accurate prognosis of critical course complications in patients with SARS-CoV-2 infection (CRIT-COV-U)
Siwy, J., Wendt, R., Keller, F., Banasik, M., Peters, B., Dudoignon, E., Mebazza, A., Gulmez, D., Spasovski, G., Lazo, M. S., Mischak, H., Hecking, M., Beige, J., UriCoV working group
10.1101/2024.06.26.24309460 — Posted: 2024-06-27
Vivaldi: An amplicon-based whole genome sequencing method for the four seasonal human coronaviruses 229E, NL63, OC43 & HKU1, alongside SARS-CoV-2
McClure, C. P., Tsoleridis, T., Holmes, N., Chappell, J. G., Byaruhanga, T., Duncan, J., Tofan, M., Khater, A., Berry, L., Clark, G., Irving, W. L., Tarr, A. W., Ball, J. K., Astbury, S., Loose, M.
10.1101/2024.06.26.24308604 — Posted: 2024-06-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).